• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们真的能预测癌症风险吗?

Can we really predict risk of cancer?

机构信息

Population Health Department, Queensland Institute of Medical Research, Queensland, Australia.

出版信息

Cancer Epidemiol. 2013 Aug;37(4):349-52. doi: 10.1016/j.canep.2013.04.002. Epub 2013 May 1.

DOI:10.1016/j.canep.2013.04.002
PMID:23643191
Abstract

BACKGROUND

Growing awareness of the potential to predict a person's future risk of cancer has resulted in the development of numerous algorithms. Such algorithms aim to improve the ability of policy makers, doctors and patients to make rational decisions about behaviour modification or surveillance, with the expectation that this activity will lead to overall benefit. There remains debate however, about whether accurate risk prediction is achievable for most cancers.

METHODS

We conducted a brief narrative review of the literature regarding the history and challenges of risk prediction, highlighting our own recent experiences in developing tools for oesophageal adenocarcinoma.

RESULTS AND CONCLUSIONS

While tools for predicting future risk of cardiovascular outcomes have been translated successfully to clinical practice, the experience with cancer risk prediction has been mixed. Models have now been developed and validated for predicting risk of melanoma and cancers of the breast, colo-rectum, lung, liver, oesophagus and prostate, and while several of these have adequate performance at the population-level, none to date have adequate discrimination for predicting risk in individual patients. Challenges of individual risk prediction for cancer are many, and include long latency, multiple risk factors of mostly small effect, and incomplete knowledge of the causal pathways.

摘要

背景

人们越来越意识到预测一个人未来癌症风险的潜力,这导致了许多算法的发展。这些算法旨在提高决策者、医生和患者在行为改变或监测方面做出合理决策的能力,期望这种活动能带来整体效益。然而,对于大多数癌症来说,是否能实现准确的风险预测仍存在争议。

方法

我们对文献进行了简短的叙述性综述,探讨了风险预测的历史和挑战,重点介绍了我们自己在开发食管腺癌工具方面的最新经验。

结果与结论

虽然预测心血管结局未来风险的工具已成功转化为临床实践,但癌症风险预测的经验却喜忧参半。目前已经开发和验证了用于预测黑色素瘤和乳腺癌、结直肠癌、肺癌、肝癌、食管癌和前列腺癌风险的模型,尽管其中一些在人群水平上具有足够的性能,但迄今为止,没有一个模型能够充分区分个体患者的风险。癌症个体风险预测面临着许多挑战,包括潜伏期长、多种风险因素大多影响较小,以及对因果途径的了解不完整。

相似文献

1
Can we really predict risk of cancer?我们真的能预测癌症风险吗?
Cancer Epidemiol. 2013 Aug;37(4):349-52. doi: 10.1016/j.canep.2013.04.002. Epub 2013 May 1.
2
Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data.根据食管腺癌发病率数据对巴雷特食管人群进行建模。
Scand J Gastroenterol. 2007 Mar;42(3):308-17. doi: 10.1080/00365520600884130.
3
Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland.苏格兰的社会经济地位与食管癌和贲门癌风险
Br J Cancer. 2000 Aug;83(3):387-90. doi: 10.1054/bjoc.2000.1110.
4
Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?巴雷特食管的监测:针对高危人群的策略能否降低食管腺癌的死亡率?
Endoscopy. 2006 Feb;38(2):162-9. doi: 10.1055/s-2005-921184.
5
Patients with prostate cancer are less likely to develop oesophageal adenocarcinoma: could androgens have a role in the aetiology of oesophageal adenocarcinoma?前列腺癌患者发生食管腺癌的可能性较低:雄激素在食管腺癌的发病机制中可能起作用?
Cancer Causes Control. 2009 Oct;20(8):1363-8. doi: 10.1007/s10552-009-9359-2. Epub 2009 May 20.
6
Cancer risk prediction models: a workshop on development, evaluation, and application.癌症风险预测模型:关于开发、评估及应用的研讨会
J Natl Cancer Inst. 2005 May 18;97(10):715-23. doi: 10.1093/jnci/dji128.
7
Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.澳大利亚前列腺癌患者三种风险评估工具的比较分析。
BJU Int. 2011 Nov;108 Suppl 2:51-6. doi: 10.1111/j.1464-410X.2011.10687.x.
8
Risk factors for esophageal cancer development.食管癌发生的危险因素。
Surg Oncol Clin N Am. 2009 Jul;18(3):469-85. doi: 10.1016/j.soc.2009.03.005.
9
Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies.食管腺癌和鳞状细胞癌与烟草相关及其他恶性肿瘤的关联。
Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):779-82.
10
Review article: oesophago-gastric adenocarcinoma -- an epidemiological perspective.综述文章:食管胃腺癌——流行病学视角
Aliment Pharmacol Ther. 2004 Oct;20 Suppl 5:55-60; discussion 61-2. doi: 10.1111/j.1365-2036.2004.02133.x.

引用本文的文献

1
Implementation of the Symptom Based Risk Calculator for Head and Neck Cancer HaNC-RC v.2 Post COVID-19 Pandemic. A Single Centre Audit.新冠疫情后基于症状的头颈癌风险计算器(HaNC-RC v.2)的实施:单中心审计
Indian J Otolaryngol Head Neck Surg. 2024 Apr;76(2):1791-1795. doi: 10.1007/s12070-023-04412-x. Epub 2023 Dec 4.
2
Metabolomics profile in gastrointestinal cancers: Update and future perspectives.胃肠癌的代谢组学特征:更新与未来展望。
World J Gastroenterol. 2020 May 28;26(20):2514-2532. doi: 10.3748/wjg.v26.i20.2514.
3
Head and neck cancer risk calculator (HaNC-RC)-V.2. Adjustments and addition of symptoms and social history factors.
头颈部癌症风险计算器(HaNC-RC)-V.2. 症状和社会史因素的调整和添加。
Clin Otolaryngol. 2020 May;45(3):380-388. doi: 10.1111/coa.13511. Epub 2020 Feb 20.
4
Do population-level risk prediction models that use routinely collected health data reliably predict individual risks?基于常规收集的健康数据的人群风险预测模型是否能可靠地预测个体风险?
Sci Rep. 2019 Aug 2;9(1):11222. doi: 10.1038/s41598-019-47712-5.
5
Epidemiology in wonderland: Big Data and precision medicine.仙境中的流行病学:大数据与精准医学。
Eur J Epidemiol. 2018 Mar;33(3):245-257. doi: 10.1007/s10654-018-0385-9. Epub 2018 Apr 5.
6
Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma.在吸烟相关肺腺癌演变过程中正常气道的全基因组基因表达变化。
Cancer Prev Res (Phila). 2018 Apr;11(4):237-248. doi: 10.1158/1940-6207.CAPR-17-0295. Epub 2018 Jan 30.
7
Patterns and predictors of first and subsequent recurrence in women with early breast cancer.早期乳腺癌女性首次和随后复发的模式和预测因素。
Breast Cancer Res Treat. 2017 Oct;165(3):709-720. doi: 10.1007/s10549-017-4340-3. Epub 2017 Jul 4.
8
Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients.乳腺癌随访的个性化:用于估计早期乳腺癌患者局部区域复发年度风险的时间依赖性预后列线图。
Breast Cancer Res Treat. 2015 Aug;152(3):627-36. doi: 10.1007/s10549-015-3490-4. Epub 2015 Jul 11.
9
Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores.前列腺MRI的哈拉里克纹理分析:用于区分非癌性前列腺与前列腺癌以及区分不同Gleason评分的前列腺癌的效用。
Eur Radiol. 2015 Oct;25(10):2840-50. doi: 10.1007/s00330-015-3701-8. Epub 2015 May 21.
10
Precision prevention of oesophageal adenocarcinoma.食管腺癌的精准预防
Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):243-8. doi: 10.1038/nrgastro.2015.24. Epub 2015 Feb 10.